PT98612A - Processo para a preparacao de uma composicao solida de dosagem oral de compostos de loperamida - Google Patents

Processo para a preparacao de uma composicao solida de dosagem oral de compostos de loperamida Download PDF

Info

Publication number
PT98612A
PT98612A PT98612A PT9861291A PT98612A PT 98612 A PT98612 A PT 98612A PT 98612 A PT98612 A PT 98612A PT 9861291 A PT9861291 A PT 9861291A PT 98612 A PT98612 A PT 98612A
Authority
PT
Portugal
Prior art keywords
loperamide
pharmaceutically acceptable
alcoholic solution
composition
compound
Prior art date
Application number
PT98612A
Other languages
English (en)
Portuguese (pt)
Inventor
Daniel Louis Barone
Francis Bernard Chapura
Shawn Alan Denny
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PT98612A publication Critical patent/PT98612A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98612A 1990-08-09 1991-08-08 Processo para a preparacao de uma composicao solida de dosagem oral de compostos de loperamida PT98612A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56501090A 1990-08-09 1990-08-09

Publications (1)

Publication Number Publication Date
PT98612A true PT98612A (pt) 1992-06-30

Family

ID=24256836

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98612A PT98612A (pt) 1990-08-09 1991-08-08 Processo para a preparacao de uma composicao solida de dosagem oral de compostos de loperamida

Country Status (9)

Country Link
EP (1) EP0542879A1 (fr)
JP (1) JPH06500104A (fr)
AU (1) AU661972B2 (fr)
CA (1) CA2088273C (fr)
FI (1) FI930536A0 (fr)
IE (1) IE912815A1 (fr)
NZ (1) NZ239308A (fr)
PT (1) PT98612A (fr)
WO (1) WO1992002223A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117834A1 (fr) * 2004-05-27 2005-12-15 Janssen Pharmaceutica N.V. Dispersions solides d'un compose medicamenteux basique et d'un polymere renfermant des groupes acides
US10508373B2 (en) 2016-05-13 2019-12-17 Nike, Inc. Embroidered article

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332236C (fr) * 1985-10-11 1994-10-04 Lourens Wals N-oxydes d'–-–-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide
DE3906779A1 (de) * 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament

Also Published As

Publication number Publication date
NZ239308A (en) 1994-04-27
IE912815A1 (en) 1992-02-12
FI930536A (fi) 1993-02-08
EP0542879A1 (fr) 1993-05-26
CA2088273C (fr) 1996-05-14
AU8440091A (en) 1992-03-02
CA2088273A1 (fr) 1992-02-10
FI930536A0 (fi) 1993-02-08
JPH06500104A (ja) 1994-01-06
WO1992002223A1 (fr) 1992-02-20
AU661972B2 (en) 1995-08-17

Similar Documents

Publication Publication Date Title
RU2648760C2 (ru) Фармацевтическая композиция, содержащая оксигидроксид железа, способ ее получения и применение
DE60133538T2 (de) Formulierung und tabletten mit guaifenesin mit verzögerter freisetzung
PT88099B (pt) Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada
JP4443119B2 (ja) モダフィニルを含んで成る固体製剤
PT87285B (pt) Processo para a preparacao de uma composicao de ibuprofeno de libertacao controlada
Adibkia et al. Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets
CN1562024A (zh) 一种治疗心血管疾病含盐酸雷诺嗪的口服制剂
NO172168B (no) Fremgangsmaate for fremstilling av faste nifedipinpreparater med hoey biotilgjengelighet og med forlenget virkning
PT85353B (pt) Processo de preparacao de composicoes farmaceuticas de libertacao controlada e de matriz a base de alcool alifatico e resina acrilica
PT86212B (pt) Processo para a preparacao de uma formulacao galenica
CN101073563B (zh) 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片
BR112012028035A2 (pt) forma de dosagem e formulação de liberação imediata, e, uso das mesmas
JP6062168B2 (ja) 生薬由来成分を含有する製剤及びその製造方法
KR20030009440A (ko) 조성물
RU2223098C2 (ru) Способ получения фармацевтической композиции для перорального введения, содержащей толперизон (варианты)
PT98791A (pt) Metodo para a preparacao de uma forma de dosagem farmaceutica a base de um sistema de matriz de libertacao constante de multiparticulas contendo goma de xantano
CN102961371B (zh) 一种精氨酸布洛芬颗粒剂及其制备方法
EP1465612A1 (fr) Comprimes de metmorphine a liberation controlee
CN1538837A (zh) 含有对乙酰氨基酚的吞咽片
JP6476331B2 (ja) イソニアジドの顆粒およびリファペンチンの顆粒を含む分散性錠剤の形態の抗結核性の安定な医薬組成物ならびにその製造方法
CN101642461B (zh) 艾拉莫德与氨基葡萄糖的药物组合物，其制备 方法和药物应用
PT98612A (pt) Processo para a preparacao de uma composicao solida de dosagem oral de compostos de loperamida
JP2013032351A (ja) 漢方又は生薬製剤及びその製造方法
CN101146519A (zh) 瓦洛他滨（val-mcyd）的固体口服剂型及其制备方法
CN105395507A (zh) 一种盐酸环苯扎林缓释片

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920226

FC3A Refusal

Effective date: 19981019